OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Northeastern University

3 Projects | 2 Researchers | $503,978 Invested

2017

Northeastern University

Alexandros Makriyannis, PhD

FAAH Inhibitors as Alzheimer's Disease Medications (2nd year continuation)

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

Northeastern University

Alexandros Makriyannis, PhD

Fatty Acid Amide Hydrolase Inhibitors as AD Medications

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed

2008

Northeastern University

Graham Jones, PhD

Expedient and Versatile Methods for the Production of Investigational Drugs for SPECT and PET Imaging of AD

  • Funding Amount: $78,978
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed